Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.
by
  • AI use cases in the pharmaceutical and healthcare industries.
  • The risks and potentials of AI in GxP as well as non-GxP processes.
  • Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

More articles

The latest industry news, interviews, technologies and resources.

Building Better Medicines: Exploring AI-Driven Compound Optimization

An expert interview on research into AI-driven drug optimization.

DNA-Encoded Libraries and AI for Compound Identification

An expert interview on the use of DNA-encoded libraries for connection detection.

Our publications

Discover the latest publications from our research team and more

Building Better Medicines: Exploring AI-Driven Compound Optimization

An expert interview on research into AI-driven drug optimization.

When biology forces better AI: What protein function prediction taught us about hierarchical data

Hyperbolic Geometry, Gene Ontology, and the Challenge of Hierarchical Representations

Data-driven to the drug of tomorrow

  • AI use cases in the pharmaceutical and healthcare industries.
  • The risks and potentials of AI in GxP as well as non-GxP processes.
  • Project report: supported document analysis for targeted identification of adverse drug reactions.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.

Discover more whitepapers

Towards Tabular Foundation Models

About the status quo, challenges and opportunities

Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage

Artificial Intelligence for Private Equity Portfolios

Increase in value for your entire portfolio

Artificial Intelligence for Private Equity Portfolios

Increase in value for your entire portfolio

Towards Tabular Foundation Models

About the status quo, challenges and opportunities

Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage

Subscribe to the Merantix Momentum Newsletter now.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.